Kopher R - Search Results

1

Circadian characteristics of cardiovascular rhythms in pregnancy.

Kopher R, Cornélissen G, Choromanski L, Eggen D, Einzig S, Vernier R, Work B, Halberg F. Kopher R, et al. Prog Clin Biol Res. 1990;341A:383-93. Prog Clin Biol Res. 1990. PMID: 2217256 No abstract available.

2

Endpoints of chronobiologic cardiovascular monitoring during pregnancy for planning exercise and assessing effects.

Crakes JG, Cornélissen G, Kopher R, Halberg F. Crakes JG, et al. Among authors: kopher r. Prog Clin Biol Res. 1990;341A:605-14. Prog Clin Biol Res. 1990. PMID: 2217279 Review.

3

Decrease in the rate of ruptured ectopic pregnancies: a successful team approach.

Rolnick S, Madden J, Stukel J, Kopher R. Rolnick S, et al. Among authors: kopher r. HMO Pract. 1994 Sep;8(3):105-9. HMO Pract. 1994. PMID: 10157225

4

Provider management of menopause after the findings of the Women's Health Initiative.

Rolnick SJ, Jackson J, Kopher R, Defor TA. Rolnick SJ, et al. Among authors: kopher r. Menopause. 2007 May-Jun;14(3 Pt 1):441-9. doi: 10.1097/GME.0b013e31802cc7bc. Menopause. 2007. PMID: 17318028

5

Provider attitudes and self-reported behaviors related to hormone replacement therapy.

Rolnick SJ, Kopher RA, Compo RB, Kelley ME, DeFor TA. Rolnick SJ, et al. Among authors: kopher ra. Menopause. 1999 Fall;6(3):257-63. doi: 10.1097/00042192-199906030-00013. Menopause. 1999. PMID: 10486797

6

Hormone use and patient concerns after the findings of the Women's Health Initiative.

Rolnick SJ, Kopher RA, DeFor TA, Kelley ME. Rolnick SJ, et al. Among authors: kopher ra. Menopause. 2005 Jul-Aug;12(4):399-404. doi: 10.1097/01.GME.0000148644.55486.36. Epub 2005 Jul 21. Menopause. 2005. PMID: 16037754

7

What is the impact of osteoporosis education and bone mineral density testing for postmenopausal women in a managed care setting?

Rolnick SJ, Kopher R, Jackson J, Fischer LR, Compo R. Rolnick SJ, et al. Among authors: kopher r. Menopause. 2001 Summer;8(2):141-8. doi: 10.1097/00042192-200103000-00010. Menopause. 2001. PMID: 11256875 Clinical Trial.

8

Assessments of prostate cancer cell functions highlight differences between a pan-PI3K/mTOR inhibitor, gedatolisib, and single-node inhibitors of the PI3K/AKT/mTOR pathway.

Sen A, Khan S, Rossetti S, Broege A, MacNeil I, DeLaForest A, Molden J, Davis L, Iversrud C, Seibel M, Kopher R, Schulz S, Laing L. Sen A, et al. Among authors: kopher r. Mol Oncol. 2025 Jan;19(1):225-247. doi: 10.1002/1878-0261.13703. Epub 2024 Aug 2. Mol Oncol. 2025. PMID: 39092562 Free PMC article.

9

Gedatolisib shows superior potency and efficacy versus single-node PI3K/AKT/mTOR inhibitors in breast cancer models.

Rossetti S, Broege A, Sen A, Khan S, MacNeil I, Molden J, Kopher R, Schulz S, Laing L. Rossetti S, et al. Among authors: kopher r. NPJ Breast Cancer. 2024 Jun 5;10(1):40. doi: 10.1038/s41523-024-00648-0. NPJ Breast Cancer. 2024. PMID: 38839777 Free PMC article.

10

Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cells.

Zou L, Kidwai FK, Kopher RA, Motl J, Kellum CA, Westendorf JJ, Kaufman DS. Zou L, et al. Among authors: kopher ra. Stem Cell Reports. 2015 Feb 10;4(2):190-8. doi: 10.1016/j.stemcr.2015.01.008. Stem Cell Reports. 2015. PMID: 25680477 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters